FI933253A - Nya amylinantagonistpeptider och anvaendning som amylinantagonister - Google Patents

Nya amylinantagonistpeptider och anvaendning som amylinantagonister Download PDF

Info

Publication number
FI933253A
FI933253A FI933253A FI933253A FI933253A FI 933253 A FI933253 A FI 933253A FI 933253 A FI933253 A FI 933253A FI 933253 A FI933253 A FI 933253A FI 933253 A FI933253 A FI 933253A
Authority
FI
Finland
Prior art keywords
amylinantagonistpeptider
amylinantagonister
nya
och anvaendning
anvaendning som
Prior art date
Application number
FI933253A
Other languages
English (en)
Other versions
FI933253A0 (fi
Inventor
Laura S L Gaeta
Howard Jones
Elisabeth Albrecht
Kathryn Prickett
Kevin Beaumont
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Publication of FI933253A0 publication Critical patent/FI933253A0/fi
Publication of FI933253A publication Critical patent/FI933253A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI933253A 1991-11-19 1993-07-16 Nya amylinantagonistpeptider och anvaendning som amylinantagonister FI933253A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/794,288 US5580953A (en) 1991-08-14 1991-11-19 Amylin antagonist peptides and uses therefor
PCT/US1992/010011 WO1993010147A1 (en) 1991-11-19 1992-11-19 Novel amylin antagonist peptides and uses therefor

Publications (2)

Publication Number Publication Date
FI933253A0 FI933253A0 (fi) 1993-07-16
FI933253A true FI933253A (fi) 1993-09-08

Family

ID=25162237

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933253A FI933253A (fi) 1991-11-19 1993-07-16 Nya amylinantagonistpeptider och anvaendning som amylinantagonister

Country Status (10)

Country Link
US (1) US5580953A (fi)
EP (1) EP0568687A1 (fi)
JP (1) JPH06504795A (fi)
AU (1) AU672589B2 (fi)
CA (1) CA2100743A1 (fi)
CZ (1) CZ168893A3 (fi)
FI (1) FI933253A (fi)
SG (1) SG44826A1 (fi)
SK (1) SK88893A3 (fi)
WO (1) WO1993010147A1 (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
WO1994018571A1 (en) * 1993-02-12 1994-08-18 Amylin Pharmaceuticals, Inc. Mcf-7 binding site assays
WO1994026292A1 (en) * 1993-05-12 1994-11-24 University Of Cincinnati Amylin antagonists and agonists
US5625032A (en) * 1993-07-21 1997-04-29 Amylin Pharmaceuticals, Inc. Selective amylin antagonist peptides and uses therefor
ES2154299T3 (es) 1993-09-07 2001-04-01 Amylin Pharmaceuticals Inc Metodos para la regulacion de la motilidad gastrointestinal.
US5739106A (en) * 1995-06-07 1998-04-14 Rink; Timothy J. Appetite regulating compositions
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
ATE491723T1 (de) 1998-02-13 2011-01-15 Amylin Pharmaceuticals Inc Neue verbindungen mit gemischter amylin aktivität
US6268474B1 (en) 1998-04-30 2001-07-31 Creighton University Peptide antagonists of CGRP-receptor superfamily and methods of use
AU2001230587A1 (en) * 2000-02-18 2001-08-27 Sumitomo Pharmaceuticals Company, Limited Drugs for ameliorating impaired glucose tolerance
EP1399740A2 (en) * 2001-06-22 2004-03-24 The University of British Columbia Type 1 diabetes diagnostics and therapeutics
US20070129307A1 (en) * 2001-06-22 2007-06-07 The University Of British Columbia Insulin epitopes for the treatment of type 1 diabetes
JP4719465B2 (ja) * 2002-09-04 2011-07-06 ディーエスエム アイピー アセッツ ビー．ブイ． インスリン感受性増強剤およびペプチド画分を含む栄養補給用および治療用組成物
WO2004023647A1 (en) 2002-09-06 2004-03-18 Telefonaktiebolaget Lm Ericsson Composite power amplifier
ES2425221T3 (es) 2003-05-30 2013-10-14 Amylin Pharmaceuticals, Llc Nuevos métodos y composiciones para suministro por vía transmucosa potenciado de péptidos y proteínas
EP1663289A2 (en) * 2003-08-29 2006-06-07 Amylin Pharmaceuticals, Inc. Methods for treating or ameliorating ghrelin-associated diseases and disorders
NZ549332A (en) 2004-02-11 2008-11-28 Amylin Pharmaceuticals Inc Amylin family peptides and methods for making and using them
US7399744B2 (en) * 2004-03-04 2008-07-15 Amylin Pharmaceuticals, Inc. Methods for affecting body composition
US20090069226A1 (en) * 2004-05-28 2009-03-12 Amylin Pharmaceuticals, Inc. Transmucosal delivery of peptides and proteins
DE102004051014A1 (de) * 2004-10-20 2006-04-27 Rwth Aachen Chemisch modifizierte Peptidanaloga
CA2583735A1 (en) 2004-10-27 2006-10-19 The Scripps Research Institute Orthogonal translation components for the in vivo incorporation of unnatural amino acids
US8394765B2 (en) * 2004-11-01 2013-03-12 Amylin Pharmaceuticals Llc Methods of treating obesity with two different anti-obesity agents
ATE427759T1 (de) 2004-11-01 2009-04-15 Amylin Pharmaceuticals Inc Behandlung von fettsucht und verbundenen erkrankungen
US8168592B2 (en) 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
WO2007104789A2 (en) 2006-03-15 2007-09-20 Novo Nordisk A/S Amylin derivatives
AU2007360979B2 (en) * 2007-11-14 2014-04-10 Amylin Pharmaceuticals, Llc Methods for treating obesity and obesity related diseases and disorders
JP5703226B2 (ja) * 2008-10-21 2015-04-15 ノヴォ ノルディスク アー／エス アミリン誘導体
BRPI1006943A2 (pt) * 2009-01-22 2021-06-15 Unigene Laboratories Inc. peptídeo, composição farmacêutica que compreende o peptídeo e método para supressão do apetite, prevenção ou tratamento de uma condição de sobrepeso ou obesidade, ou para tratar diabetes
CA2967616A1 (en) * 2016-09-19 2018-03-19 The Governors Of The University Of Alberta Brain penetrant amylin receptor based peptides for alzheimer's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) * 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
EP0348490B1 (en) * 1988-01-11 1995-09-27 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
NZ234428A (en) * 1989-07-10 1997-08-22 Amylin Corp Use of an amylin antagonist in the treatment of obesity and essential hypertension
US5175146A (en) * 1989-12-05 1992-12-29 Vical, Inc. Synthetic calcitonin peptides
US5264372A (en) * 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists

Also Published As

Publication number Publication date
WO1993010147A1 (en) 1993-05-27
SG44826A1 (en) 1997-12-19
SK88893A3 (en) 1994-03-09
US5580953A (en) 1996-12-03
CZ168893A3 (en) 1994-04-13
CA2100743A1 (en) 1993-05-20
EP0568687A1 (en) 1993-11-10
AU3143193A (en) 1993-06-15
AU672589B2 (en) 1996-10-10
JPH06504795A (ja) 1994-06-02
FI933253A0 (fi) 1993-07-16

Similar Documents

Publication Publication Date Title
FI933253A (fi) Nya amylinantagonistpeptider och anvaendning som amylinantagonister
FI922735A (fi) Nya behaollarsystem och vattenhaltiga kompositioner
FI921952A (fi) Foerfarande foer framstaellning av dialkylenpiperidinofoereningar och enantiomerer daerav anvaendbara som laekemedel
FI924557A0 (fi) Nya fenylpyrazolfungicider
FI924077A (fi) Nya omaettade acykliska purin- och pyrimidinfosfonatderivat
FI934373A (fi) Fabrikationsprocess av komposittraod och kompositprodukter som faotts avnaemnda traoden
FI921135A (fi) Nya karbonsyraamider
FI933451A (fi) Nya steroidestrar
FI925174A0 (fi) Nya organokiselfoereningar och kompositioner innehaollande dem
FI933450A0 (fi) Nya steroider
FI923756A (fi) Polyolefinkompositioner som omfattar glycerolmonoestrar av c20-24-fettsyror och daerav framstaellda skumprodukter
FI925946A0 (fi) Nya 2-sackarinylmetylaryl- och -aryloxiacetat anvaendbara som inhibitorer foer proteolytiska ensymer, kompositioner innehaollande dessa och anvaendning av dessa
FI906334A0 (fi) Nya e-vitaminderivat och foerfarande foer framstaellning daerav.
FI925086A0 (fi) Nya hybrid-vaextfaktorer
FI921614A (fi) Nya herbicider
FI923872A (fi) Nya bensopyranderivat
FI921596A (fi) Tetron- och tiotetronsyraderivat och fosfolifas a2 som inhibitorer
FI930293A (fi) Nya heteroaryloxi-b-karboliner, deras framstaellning och anvaendning i laekemedel
FI922472A (fi) Gingerol- och gingerdiolderivat som hypokolesterolemiska och antiaterosklerostiska medel
FI922552A (fi) Nya kefemfoereningar
FI934574A (fi) Nya mikroorganismer och nya enzymer
FI923304A (fi) Nya bearbetbara tiofenbaserade polymerer och kopolymerer, och vaermestabila elledande kompositioner daerav
FI924986A0 (fi) Nya dietylentriaminderivat och anvaendning av dessa foer diagnostiska och terapeutiska aendamaol
FI925722A (fi) Nya tiazoler
FI924883A (fi) Nya alkaloider och foerfaranden foer produktion daerav

Legal Events

Date Code Title Description
FD Application lapsed